Post-authorization Safety Study Evaluation of Neoplasm Events in Users of Mirabegron and Other Treatments for Overactive Bladder : Core Common Protocol

ENCePP Code of conduct

No

Data sources

• Data source(s):
  Clinical Practice Research Datalink

  Danish registries (access/analysis)

  Sweden National Prescribed Drugs Register / Läkemedelsregistret
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Disease registry

  Drug dispensing/prescription data

  Electronic healthcare records (EHR)

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No